@article{AMJ4277,
author = {ManHee Suh and Lei Sun},
title = {Antibiotics in cancer patients: is the verdict still out?},
journal = {AME Medical Journal},
volume = {3},
number = {1},
year = {2018},
keywords = {},
abstract = {Immune checkpoint inhibitors (ICI) have shown tremendous successes on treatment of multiple tumor malignancies, offering a valuable but rare commodity to both patients and researchers (1-3). As an important part of tumor immunotherapies, ICIs inspire the once-questioned idea that although inhibited our immune system is able to eliminate tumor cells in a similar way that it does to infectious microorganisms. ICIs can release the brakes imposed by the tumor on this fabulous capability, which then heightens the immune response against tumor cells.},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/4277}
}